Opening with an overview on developments over the past year, Mr Adrian Shephard from RB highlighted three recent activities that indicate progress towards tackling the issue of AMR:
1. In May new guidance on the treatment of Acute Sore Throat was published by NICE in the UK. This guidance specifically encouraged GPs to stop the routine dispensing of antibiotics and reserve these drugs for patients whose symptoms indicate they will truly benefit
2. On a Global scale, the WHO and their partners such as the World Organisation for Animal Health (OIE) have united under the One Health approach to take collective action to minimize the emergence and spread of AMR by promoting the prudent and responsible use of antimicrobial agents
3. The five pillars set out in the Global Action Plan to address AMR are being translated into National Action Plans (NAPs) in different countries across the world.
The major battleground in the community continues to be
the inappropriate prescribing of antibiotics for self-limiting respiratory tract infections
Mr Adrian Shephard
Mr Shephard reflected that the increase in the number of countries who have now published NAPs to counter inappropriate antibiotic use is remarkable. There was a huge surge in 2017 that continued into early 2018. We now see the majority of the countries have a NAP and within those plans there are commonalities around the five pillars from the WHO